| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |